This article explores challenges to accessing opioid treatment programs in rural areas, and offers solutions that would ease these problems.
Get full access to this article
View all access options for this article.
References
1.
K. A.Mack, C. M.Jones, and M. F.Ballesteros, “Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas—United States,”American Journal of Transplantation17 (2017), 3241-3252.
B.Nosyk, M.D.Anglin, S.Brissette, T.Kerr, D.C.Marsh, B.R.Shackman, E.Wood, and J.S.Montaner, “A Call for Evidence-Based Medical Treatment of Opioid Dependence in the United States and Canada,”Health Affairs32, no. 8 (2013): 1462-1469, at 1462-1463.
4.
J. D.Lee, P. D.Friedmann, T. W.Kinlock, E. V.Nunes, T. Y.Boney, R. A.HoskinsonJr., and M.Gordon, “Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders,”New England Journal of Medicine374 (2016): 1232-1242.
5.
R. P.Mattick, R.Ali, J. M.White, S.O’brien, S.Wolk, and C.Danz, “Buprenorphine versus Methadone Maintenance Therapy: A Randomized Double-Blind Trial with 405 Opioid-Dependent Patients,”Addiction98, no. 4 (2003): 441-452. See also B. Mund and K. Stith, “Buprenorphine MAT as an Imperfect Fix,” The Journal of Law, Medicine & Ethics 46, no. 2 (2018): 279-291.
6.
R. P.Mattick, J.Kimber, C.Breen, and M.Davoli, “Buprenorphine Maintenance versus Placebo or Methadone Maintenance for Opioid Dependence,”Cochrane Database System Review2, no. 2 (2008).
7.
C. M.Jones, M.Campopiano, G.Baldwin, and E.McCance-Katz, “National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment,”American Journal of Public Health105, no. 8 (2015): e55-e63.
8.
A. W.Dick, R. L.Pacula, A. J.Gordon, M.Sorbero, R. M.Burns, D.Leslie, and B. D.Stein, “Growth in Buprenorphine Waivers for Physicians Increased Potential Access to Opioid Agonist Treatment, 2002–11,”Health Affairs34, no. 6 (2015): 1028-1034.
L.Chan, L. G.Hart, and D. C.Goodman, “Geographic Access to Health Care for Rural Medicare Beneficiaries,”The Journal of Rural Health22, no. 2 (2006): 140-146.
11.
J. E.Billi, C. W.Pai, and D. A.Spahlinger, “The Effect of Distance to Primary Care Physician on Health Care Utilization and Disease Burden,”Health Care Management Review32, no. 1 (2007): 22-29.
12.
S.Reif, C. E.Golin, and S. R.Smith, “Barriers to Accessing HIV/AIDS Care in North Carolina: Rural and Urban Differences,”AIDS Care17, no. 5, (2005): 558-565.
13.
S.C.Sigmon, “Access to Treatment for Opioid Dependence in Rural America: Challenges and Future Directions,”JAMA Psychiatry71, no. 4 (2014): 359-360, at 359.
